Guidelines on the optimal and rational supply of medicines to avoid shortages during the COVID-19 outbreak

Summary:

Communication published by the European Commission on 8 April 2020, setting out a number of guidelines relating to the supply and availability of medicines in the context of the COVID-19 outbreak.

Further information:

The guidelines aim to protect public health and preserve the integrity of the single market, whilst ensuring that the European Union (EU) has the supply of affordable medicines it needs during the pandemic. They focus on the rational supply, allocation and use of medicines to treat coronavirus patients. They also cover any medicine at risk of shortage due to the outbreak.

• Primary Source

Official

European Commission: Press Release, 08/04/2020: Coronavirus: Commission calls on Member States to optimise supply and availability of medicines https://ec.europa.eu/commission/presscorner/detail/en/ip_20_622

---